Skip to main content
Clinical Trials/NCT06051097
NCT06051097
Completed
Not Applicable

Relationship Between Metabolic Syndrome and Obstructive Sleep Apnea

Cairo University1 site in 1 country80 target enrollmentSeptember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep Apnea
Sponsor
Cairo University
Enrollment
80
Locations
1
Primary Endpoint
Predictors of metabolic syndrome among OSA patients
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Background:Metabolic syndrome is a disorder characterized by abdominal obesity,hypertension,increased triglycerides ,decreased HDL cholesterol and increased blood glucose. Accumulating evidence strongly indicates that insulin resistance and an increased amount of abdominal fat are the pathogenic factors for the characteristics of metabolic syndrome. Studies indicate that sleep apnea may be a manifestation of the metabolic syndrome.

Subjects and methods:This study was conducted in the pulmonology department at kasrelainy hospital. It included 80 patients who came to the sleep lab unit for polysomnography. Each patient was subjected to full history taking including(sex,age,smoking history,presence of diabetes or hypertension),thorough clinical examination with emphasis on waist, neck&hip circumference and blood pressure measurements,Laboratory investigations including :Lipid profile& Diabetic profile(HBA1C).In addition to ESS and stop bang score questionnaire.

Registry
clinicaltrials.gov
Start Date
September 1, 2022
End Date
May 15, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eman Kamal Ibrahim Hassan

Assistant Professor of pulmonology

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Patients fulfilled the criteria of OSA ( obstructive sleep apnea) in the form of symptoms suggestive of OSA (daytime sleepiness/daytime fatigue/headache/snoring)and with AHI ( apnea-hyponea index) ≥5.

Exclusion Criteria

  • Cerebro-vascular accident within the preceding 30 days.
  • Patients on sedatives.
  • Patients on anti-psychotics

Outcomes

Primary Outcomes

Predictors of metabolic syndrome among OSA patients

Time Frame: 6 months

evaluation of factors related to occurrence of metabolic syndrome in OSA such as age(in years),weight in kilograms(kg) and height in meters (m) will not be measured separately but combined to assess BMI( weight in kg/ height in m2) and oxygen saturation (O2%), evaluation of polysomnographic data and laboratory tests in the form of lipid profile in (mg/dl) and HBA1C (g/dl)

Study Sites (1)

Loading locations...

Similar Trials